Antengene IPO Initiation: Hunting for a Cure
Leveraging the management team’s expertise, Antegene focuses on the haematology and oncology therapeutic areas. Overall, we believe that Antegene’s...
313 Views
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
451 Views
ECM Weekly (9 August 2020) - KE Holdings, Pop Mart, Everest Med, KWG Living, E-Star Comm
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong...
568 Views
Tigermed IPO: Trading Debut
Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
416 Views
Tigermed (泰格医疗) A+H Trading: Insti Buying to Continue Post Listing
Hangzhou Tigermed raised HKD 10,272 million (USD 1.3 bn) from its global offering and will list on the Hong Kong Stock Exchange tomorrow. In our...
402 Views